Findings indicate that dapagliflozin and calorie restriction together improve weight loss and metabolic health, increasing ...

The combined regimen achieved a higher remission rate than calorie restriction alone in people with overweight or obesity and ...

The results of this cohort study suggest that individuals with type 2 diabetes who initiated treatment with empagliflozin or ...

FRIDAY, Jan. 24, 2025 (HealthDay News) -- People can reverse their type 2 diabetes through a combination of calorie cutting ...

No randomized clinical trials have directly compared empagliflozin with dapagliflozin for type 2 diabetes, so investigators conducted a large comparative effectiveness study examining kidney outcomes.

A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.

"These findings reinforce the use of dapagliflozin, 10 mg, or other SGLT2 inhibitors when the therapeutic goal is to reduce ...

The researchers note that the cardiovascular benefits and safety of SGLT-2 inhibitors have primarily been studied in placebo-controlled trials, leaving the comparative effectivene ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher ...

Dapagliflozin alongside moderate calorie restricted diet leads to much higher rates of remission from early type 2 diabetes, ...

Combined strategy is effective but questions remain The view that the hyperglycaemia associated with type 2 diabetes is inexorably progressive was challenged by the publication of the DiRECT study in ...

In keeping with current guidelines, either empagliflozin or dapagliflozin can be used for preventing AKI and CKD in patients with type 2 diabetes. Empagliflozin and dapagliflozin are equally ...